Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment

Acute kidney injury and chronic kidney disease is common in multiple myeloma. Fludarabine which is part of lymphodepletion before CAR-T cell therapy is renally eliminated and its use is not recommended for patients with severe renal impairment defined as a glomerular filtration rate below 30ml/min/1...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquard, Franziska, Langebrake, Claudia, Janson, Dietlinde, Mahmud, Maida, Dadkhah, Adrin, Kröger, Nicolaus, Ayuk, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682764/
https://www.ncbi.nlm.nih.gov/pubmed/38033500
http://dx.doi.org/10.3389/fonc.2023.1288764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682764/
https://www.ncbi.nlm.nih.gov/pubmed/38033500
http://dx.doi.org/10.3389/fonc.2023.1288764

Ejemplares similares